期刊文献+

双膦酸盐类药物治疗相关的下颌骨坏死的研究进展 被引量:3

Progress in Study of Osteonecrosis of the Mandible Associated with Bisphosphonates Therapy
下载PDF
导出
摘要 双膦酸盐类药物是焦膦酸盐分子的稳定类似物,是抗骨吸收类药物,作用机制明确,近年来在临床上广泛应用。常用于治疗骨质疏松症、变形性骨炎、恶性肿瘤骨转移引起的高钙血症和骨痛症等难治性病症,收到良好效果。但是,治疗中由于选用适应证和使用浓度不同,治疗后出现一些并发症,特别是下颌骨坏死的报道。现就与双膦酸盐治疗相关的下颌骨坏死进行综述,供口腔科医师参考。 Bisphosphonates are stable pyrophosphate analogues and antiresorptive drugs with clear mechanism of action and extensive clinical application in recent years.Bisphosphonates are commonly used and effective in treating osteoporosis,osteitis deformans,hypercalcemia and ostalgia caused by bone metastasis of malignant tumors,and other refractory illness.However,reports of post-therapeutic complications,especially osteonecrosis of the mandible,are seen as results of different selections of indications and concentrations.In this article,bisphosphonates-induced osteonecrosis of the mandible is reviewed to provide reference for dentists in clinical practice.
作者 彭诚 王东
出处 《医学综述》 2011年第8期1181-1183,共3页 Medical Recapitulate
关键词 双膦酸盐 下颌骨坏死 恶性肿瘤 骨质疏松 Bisphosphonates Mandibular osteonecrosis Malignant tumor Osteoporosis
  • 相关文献

参考文献16

  • 1Pogrel MA.Bisphosphonates and bone necrosis[J].J Oral Maxillofac Surg,2004,62(3):391-392.
  • 2Wang J,Goodger NM,Pogrel MA.Osteonecrosis of the jaws associated with cancer chemotherapy[J].J Oral Maxillofac Surg,2003,61(9):1104-1107.
  • 3郭宏,刘洪臣.双膦酸盐类药物治疗骨质疏松症的研究进展[J].广东牙病防治,2008,16(5):238-240. 被引量:2
  • 4Marx RE,Sawatari Y,Fortin M,et al.Bisphosphonate induced exposed bone(osteonecrosis/osteopetrosis)of the jaw[J].J Oral Maxillofac Surg,2005,63(11):1567-1575.
  • 5Shinoda H,Takeyama S,Suzuki K,et al.Pharmacological topics of bone metabolism:a novel bisphosphonate for the treatment of periodontitis[J].J Pharmacol Sci,2008,106(4):555-558.
  • 6Woo SB,Hellstein JW,Kalmar JR.Narrative[corrected] review:bisphosphonates and osteonecrosis of the jaws[J].Ann Int Med,2006,144(10):753-761.
  • 7Sarathy AP,Bourgeois SL Jr,Goodell GG.Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment:two case reports[J].J Endod,2005,31(10):759-763.
  • 8Reuther T,Schuster T,Mende U,et al.Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients--a report of a thirty year retrospective review[J].Int J Oral Maxillofac Surg,2003,32(3):289-295.
  • 9Ibrahim T,Barbanti F,Giorgio-Marrano G,et al.Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates:a retrospective study[J].Oncologist,2008,13(3):330-336.
  • 10Pongchaiyakul C,Auraiwan K,Kotruchin P,et al.Bisphosphonate-related osteonecrosis of the jaws (ONJ):a report of two cases[J].J Med Assoc Thai,2007,90(11):2494-2498.

二级参考文献22

  • 1ROBERT M, DAVID F, JENNIFER K. Osteoporosis. 2nd ed. New York: Academic Press, 2001.
  • 2CHAIAMNUAY S, SAAG K G. Rev Endoer Metab Disord, 2006,7 (1-2) :101-112.
  • 3ROGERS M J, GORDON S, BENFORD H L, et al. Cancer, 2000, 88(Suppl12) :2961-2978.
  • 4BENFORD H L, MCGOWAN N W, HELFRICH M H, et al. Bone, 2001,28(5 ) :465-473.
  • 5PLOTKIN L I, WEINSTEIN R S, PARFITT A M, et al. J Clin Invest, 1999,104(10) :1363-1374.
  • 6LIBERMAN U A, WEISS S R, BROLLJ, et al. N Engl J Med, 1995,333 (22) : 1437-1443.
  • 7ROSEN C J, HOCHBERG M C, BONNICK S L, et al. J Bone Miner Res, 2005,20( 1 ) :141-151.
  • 8CRANNEY A, WELLS G, WILLAN A, et al. Endocr Rev, 2002, 23(4) :508-516.
  • 9PAPAPOULOS S E, QUANDT S A, LIBERMAN U A, et al. Osteoporos Int, 2005,16 (5) :468-474.
  • 10SCHNITZER T, BONE H G, CREPALDI G, et al. Aging(Milano), 2000,12(1) :1-12.

共引文献1

同被引文献36

  • 1张众志,陈璐璐,李裕明.二膦酸盐细胞分子作用机制的研究进展[J].中国骨质疏松杂志,2004,10(3):390-392. 被引量:15
  • 2项如莲,陈其,徐强,吴蓉洲,张琦,李焕斌.^(99)Tc^m和^(67)Ga心肌显像在小儿病毒性心肌炎中的应用[J].中华核医学杂志,2004,24(5):284-287. 被引量:13
  • 3周际昌.实用肿瘤内科学[M].第2版.北京:人民卫生出版社,2005.386-388.
  • 4Rayman S, Almas K, Dincer E. Bisphosphonate-related jaw necrosis:a team approach management and prevention[J]. Int J Dent Hyg,2009,7(2) :90-5.
  • 5胡云峰,雷侠.单纯放疗与放疗联合唑来膦酸治疗骨转移瘤临床观察[J].现代肿瘤医学,2008,16(1):112-113. 被引量:10
  • 6Ruggiero SL,Dodson TB,Assael LA,et al.American association of oral and maxillofacial surgeons position paper on bisphosphonate- related osteonecrosis of the jaws-2009 update[J I.J Oral Maxillofac Surg,2009,67(5 Suppl):2-12.
  • 7Christodoulou C,Pervena A,Klouvas G,et al.Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone [J].Oncology,2009,76(3):209-11?.
  • 8Bi Y,Gao Y,Ehirchiou D,et al.Bisphosphonates cause osteonecrosis of the jaw-like disease in mice [J].Am J Pathol,2010,177(1):280-90.
  • 9Weidner N.Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors [J].Breast Cancer Res Treat,1995,36(2):169-80.
  • 10Bolomsky A,Schreder M,MeiBner T,et al.Immunomodulatory drugs Thalidomide and lenalidomide affect osteoblast differentiation of human bone marrow stromal cells in vitro [J].Exp Hematol,2014,42(7):516-25.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部